Advertisement

What is prostatic ductal adenocarcinoma? How is it clinically and pathologically different from the conventional (acinar) adenocarcinoma?

Abstract

Most adenocarcinomas of the prostate are composed of cuboidal cells characteristic of prostate acini. Therefore, they are defined as acinar adenocarcinoma. Prostate adenocarcinoma characterized by tall columnar cells resembling prostatic ductal cells is defined as ductal adenocarcinoma. Tumor cells are arranged in papillary, complex glandular (cribriform), comedo or solid architectures. Ductal adenocarcinomas usually behave more aggressively than acinar-type adenocarcinoma. They may be periurethral in location and present with hematuria and obstructive symptoms. Ductal adenocarcinoma may occur peripherally without obstructive symptoms and be discovered by prostate needle core biopsy performed for elevated prostate-specific antigen (PSA) levels.

Keywords

Radical Prostatectomy Prostatic Adenocarcinoma Prostatic Intraepithelial Neoplasia Cribriform Pattern Prostatic Duct 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Melicow DG, Pachter MR (1971) Endometrial carcinoma of prostatic utricle (uterusmasculinus). Cancer 20:1715–1721.CrossRefGoogle Scholar
  2. 2.
    Bostwick DG, Kindrachuk RW, Rouse RV (1985) Prostatic adenocarcinoma with endometrial features: clinical, pathological, and ultrastructural findings. Am J Surg Pathol 9:596–609.Google Scholar
  3. 3.
    Epstein JI, Wooddruff J (1986) Prostatic carcinoma with endometrioid features: a light microscopic and immunohistochemical study of 10 cases. Cancer 57:111–119.PubMedCrossRefGoogle Scholar
  4. 4.
    Yang XJ, Cheng LB, Helpap B, Samaratunga HM (2004) Ductal adenocarcinoma of the prostate. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds) WHO Classification of Tumours. Tumours of the Urinary System and Male Genital Organs. IARC Press, Lyon, pp 199–201.Google Scholar
  5. 5.
    Dube VE, Farrow GM, Green LF (1973) Prostatic adenocarcinoma of ductal origin. Cancer 32:402–409.PubMedCrossRefGoogle Scholar
  6. 6.
    Samaratunga H, Singh M (1997) Distribution pattern of basal cells detected by cytokeratin 34betaE12 in primary prostatic duct adenocarcinoma. Am J Surg Pathol 21:435–440.PubMedCrossRefGoogle Scholar
  7. 7.
    Christensen WN, Steinberg WN, Walsh PC, Epstein JI (1991) Prostatic duct adenocarcinoma: findings at radical prostatectomy. Cancer 67:2118–2124.PubMedCrossRefGoogle Scholar
  8. 8.
    Brinker DA, Potter SR, Epstein JI (1999) Ductal adenocarcinoma of the prostate diagnosed on needle biopsy: correlation with clinical and radical prostatectomy findings and progression. Am J Surg Pathol 23:1471–1479.PubMedCrossRefGoogle Scholar
  9. 9.
    Aydin F (1993) Endometrioid adenocarcinoma of prostatic urethra presenting with anterior urethral implantation. Urology 41:91–95.PubMedCrossRefGoogle Scholar
  10. 10.
    Millar EKA, Sharma NK, Lessels EM (1996) Ductal (endometrial) adenocarcinoma of the prostate: a clinicopathologic study of 16 cases. Histopathology 29:11–19.PubMedCrossRefGoogle Scholar
  11. 11.
    Tannenbaum M (1975) Endometrial tumors and/or associated carcinomas of prostate. Urology 6:372–375.PubMedCrossRefGoogle Scholar
  12. 12.
    Greene LF, Farrow GM, Ravits JM, Tomera FM (1979) Prostatic adenocarcinoma of ductal origin. J Urol 121:303–305.PubMedGoogle Scholar
  13. 13.
    Ro JY, Ayala AG, Wishnow KI, Ordonez NG (1988) Prostatic duct adenocarcinoma with endometrioid features: immunohistochemical and electron microscopic features. Semin Diagn Pathol 5:301–311.PubMedGoogle Scholar
  14. 14.
    Oesterling JE, Brendler CB, Epstein JI, Kimball AW, Walsh PC (1987) Correlation of clinical stage, serum prostatic acid phosphatase, and preoperative Gleason grade with final pathologic stage in 275 patients with clinically localized adenocarcinoma of the prostate. J Urol 138:92–98.PubMedGoogle Scholar
  15. 15.
    Epstein JI, Partin AW, Sauvageot J, Walsh PC (1996) Prediction of progression following radical prostatectomy: a multivariate analysis of 721 men with long-term follow-up. Am J Surg Pathol 20:286–292.PubMedCrossRefGoogle Scholar
  16. 16.
    August CZ, Oyasu R (1983) Adenocarcinoma of the prostate gland: a spectrum of differentiation. Arch Pathol Lab Med 107:501–502.PubMedGoogle Scholar
  17. 17.
    Bock BJ, Bostwick DG (1999) Does prostatic duct adenocarcinoma exist? Am J Surg Pathol 23:781–785.PubMedCrossRefGoogle Scholar
  18. 18.
    Kovi J, Jackson MA, Heshmat MY (1985) Ductal spread in prostatic carcinoma. Cancer 56:1566–1573.PubMedCrossRefGoogle Scholar
  19. 19.
    McNeal JE, Yemoto CEM (1996) Spread of adenocarcinoma within prostatic ducts and acini: morphologic and clinical correlations. Am J Surg Pathol 20:802–814.PubMedCrossRefGoogle Scholar
  20. 20.
    Rubin MA, de La Taille A, Bagiella E, Olsson CA, O’Toole KM (1998) Cribriform carcinoma of the prostate and prostatic intraepithelial neoplasia: incidence and clinical implications. Am J Surg Pathol 22:840–848.PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2008

Personalised recommendations